Fig. 3.

NS1 BOB analysis of Brazilian samples. (A–C) Percentage of BOB in samples from (A) ZIKV-infected subjects versus the days postsymptom onset; (B) patients with Zika with several time points available, categorized as T1 (0–5 d), T2 (6–10 d), and T3 (>10 d); and (C) ZIKV-naive samples from subjects infected with measles virus, rubella, cytomegalovirus, hepatitis A virus, hepatitis B virus, and hepatitis C virus, as well as immunized with the YFV vaccine. Shown is the number of samples positive (i.e., BOB percentage >50%) out of the total.